Home > Qtrly Results > AJANTA PHARMA

AJANTA PHARMA
Quarterly Results Analysis [Dec2023]

AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Sep2022
Audited
Jun2022
UnAudited
Mar2022
UnAudited
Revenues ₹1,105 Cr ₹1,028 Cr ₹1,021 Cr ₹882 Cr ₹972 Cr ₹938 Cr ₹951 Cr ₹870 Cr
Expenses ₹791 Cr ₹738 Cr ₹750 Cr ₹732 Cr ₹802 Cr ₹742 Cr ₹729 Cr ₹664 Cr
Operating Income ₹314 Cr ₹291 Cr ₹271 Cr ₹149 Cr ₹170 Cr ₹196 Cr ₹222 Cr ₹207 Cr
Other Income ₹14 Cr ₹21 Cr ₹32 Cr ₹37 Cr ₹35 Cr ₹40 Cr ₹33 Cr ₹29 Cr
Interest ₹2 Cr ₹2 Cr ₹1 Cr ₹1 Cr ₹3 Cr ₹1 Cr ₹1 Cr ₹7 Cr
Depreciation ₹34 Cr ₹34 Cr ₹33 Cr ₹33 Cr ₹33 Cr ₹33 Cr ₹32 Cr ₹31 Cr
Profit Before Tax ₹291 Cr ₹276 Cr ₹269 Cr ₹152 Cr ₹168 Cr ₹203 Cr ₹222 Cr ₹198 Cr
Profit After Tax ₹210 Cr ₹195 Cr ₹208 Cr ₹122 Cr ₹135 Cr ₹157 Cr ₹175 Cr ₹151 Cr
EPS ₹16.62 ₹15.46 ₹16.47 ₹9.68 ₹10.46 ₹12.18 ₹13.58 ₹11.74
Industry Peers & Returns1W1M1Y
AJANTA PHARMA 5.4% 4.4% 78.1%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

AJANTA PHARMA Quarterly Revenues

Revenues
Q-o-Q

7.46 %

Y-o-Y

13.73 %

Quarters Revenues % Change
Dec2023 ₹1,105 Cr
7.46
Sep2023 ₹1,028 Cr
0.72
Jun2023 ₹1,021 Cr
15.79
Mar2023 ₹882 Cr
-9.25
Dec2022 ₹972 Cr
3.59
Sep2022 ₹938 Cr
-1.35
Jun2022 ₹951 Cr
9.27
Mar2022 ₹870 Cr -

AJANTA PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

8.05 %

Y-o-Y

85.24 %

Quarters Operating Profit % Change
Dec2023 ₹314 Cr
8.05
Sep2023 ₹291 Cr
7.13
Jun2023 ₹271 Cr
81.64
Mar2023 ₹149 Cr
-11.90
Dec2022 ₹170 Cr
-13.64
Sep2022 ₹196 Cr
-11.46
Jun2022 ₹222 Cr
7.29
Mar2022 ₹207 Cr -
Operating Margins
Q-o-Q

0.57 %

Y-o-Y

62.87 %

Quarters Operating Margin% % Change
Dec2023 28.42%
0.57
Sep2023 28.26%
6.36
Jun2023 26.57%
56.85
Mar2023 16.94%
-2.92
Dec2022 17.45%
-16.63
Sep2022 20.93%
-10.25
Jun2022 23.32%
-1.81
Mar2022 23.75% -

AJANTA PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

7.54 %

Y-o-Y

56.14 %

Quarters Profit After Tax % Change
Dec2023 ₹210 Cr
7.54
Sep2023 ₹195 Cr
-6.16
Jun2023 ₹208 Cr
70.24
Mar2023 ₹122 Cr
-9.11
Dec2022 ₹135 Cr
-14.11
Sep2022 ₹157 Cr
-10.32
Jun2022 ₹175 Cr
15.48
Mar2022 ₹151 Cr -
PAT Margins
Q-o-Q

0.05 %

Y-o-Y

37.28 %

Quarters PAT Margin(%) % Change
Dec2023 19 %
0.05
Sep2023 18.99 %
-6.82
Jun2023 20.38 %
47.04
Mar2023 13.86 %
0.14
Dec2022 13.84 %
-17.08
Sep2022 16.69 %
-9.10
Jun2022 18.36 %
5.70
Mar2022 17.37 % -

AJANTA PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

7.50 %

Y-o-Y

58.89 %

Quarters EPS % Change
Dec2023 ₹16.62
7.50
Sep2023 ₹15.46
-6.13
Jun2023 ₹16.47
70.14
Mar2023 ₹9.68
-7.46
Dec2022 ₹10.46
-14.12
Sep2022 ₹12.18
-10.31
Jun2022 ₹13.58
15.67
Mar2022 ₹11.74 -

You may also like the below Video Courses